The serum levels of sE-selectin are increased in patients with bullous pemphigoid or pemphigus vulgaris. Correlation with the number of skin lesions and recovery after corsticosteroid therapy

British Journal of Dermatology

Volumn 137, Issue 1, 1997, Pages 59-64

  D'Auria, L ^a   Cordiali Fei, P ^a   Pietravalle, M ^a   Ferraro, C ^a   Mastroianni, A ^a   Bonifati, C ^a   Giacalone, B ^a   Ameglio, F ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C3; CORTICOSTEROID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN; INTERCELLULAR ADHESION MOLECULE 1; METHYLPREDNISOLONE; PROTEIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; IMMUNOPHENOTYPING; INTRAVENOUS DRUG ADMINISTRATION; MALE; PEMPHIGOID; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; SERUM; SKIN BIOPSY;

EID: 8544243457     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03701.x     Document Type: Article

References (33)

1. Kian-Aung U, Haskard DO, Poston RN et al. Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol 1991: 146: 521-8.
2. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte migration: the multistep paradigm. Cell 1994; 76: 301-14.
3. Leeuwenberg JFM, Smeets EF, Neefjes JJ et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells 'in vitro'. Immunology 1992; 77: 545-9.
4. Saurat JH. Maladies bulleuses. In: Dermatologie et Venereologie, 2nd edn, Paris: Masson. 1990; 231-76.
5. Fabbri P. Dermatosi da alterata immunoregolazione. Malattie autoimmuni cutanee. In: Immunodermatologia. Brescia: ISED. 1993; 224-79.
6. Sams WM, Gammon WR. Mechanisms of lesion production in pemphigus and pemphigoid. J Am Acad Dermatol 1982; 6: 431-49.
7. Shirakata Y, Shiraishi S, Sayama K, Mikj Y. Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus. J Dermatol 1990; 17: 661-6.
8. Jordon RE. Complement activation in bullous skin diseases. J Invest Dermatol 1975; 65: 162-9.
9. Groves RW, Allen MH, Barker JNWN et al. Endothelial leukocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol 1991; 124: 117-23.
10. Koch AE, Turkievicz W, Harlow LA, Pope RM. Soluble E-selectin in arthritis. Clin Immunol Immunopathol 1993; 69: 29-35.
11. Machold KP, Kiener HP, Graninger W, Graninger WB. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol 1993: 68: 74-8.
12. Kobayashi T, Hashimoto S, Imai K et al. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma. Clin Exp Immunol 1994; 96: 110-5.
13. Hirai S, Kageshita T, Tsujisaki M et al. Soluble intercellular adhesion molecule-1 and soluble E-selectin levels in patients with atopic dermatitis. Br J Dermatol 1996; 134: 657-61.
14. Carducci M, Mussi A, Bonifati C et al. sICAM-1, sIL-2R and beta-2-microglobulin serum levels in patients affected with psoriasis: relationships with disease severity. Arch Dermatol Res 1994; 286: 420-1.
15. Bonifati C, Trento E, Carducci M et al. Soluble E-selectin levels and soluble tumor necrosis factor receptor (60kD) serum levels in patients with psoriasis. Dermatology 1995; 190: 128-31.
16. Ameglio F, Bonifati C, Carducci M et al. Serum soluble E-selectin levels decrease early during effective therapy in psoriatic patients. Eur J Dermatol 1995; 5: 512-5.
17. Karashima T, Hachisuka H, Okubo K, Sasai Y. Epidermal keratinocytes of bullous pemphigoid express intercellular adhesion molecule-1 (ICAM-1). J Dermatol 1992: 19: 82-6.
18. Rose NR, de Macario EC, Fahey JL et al. Manual of Clinical Laboratory Immunology, 4th edn. Washington, DC: American Society for Microbiology, 1992.
19. Snedecor GW, Cochran WG. Statistical Methods, 6th edn. Ames, USA: The Iowa State University Press, 1967.
20. Yamamura M, Wang XH, Ohmen JD et al. Cytokine patterns of immunologically mediated tissue damage. J Immunol 1992; 149: 1470-5.
21. Delaporte E, Bieber T, Viac J et al. Cytokines épidermiques et inflammation cutanée. Ann Dermatol Venereol 1994; 121: 836-43.
22. Bos JD, Kapsenberg ML. The skin immune system: progress in cutaneous biology. Immunol Today 1993; 14: 75-8.
23. Schroder JM. Cytokine networks in the skin. J Invest Dermatol 1995; 105 (Suppl.): 20S-24S.
24. Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1 and VCAM-1: pathological significance. Ann NY Acad Sci 1992; 667: 324-31.
25. Pigott R, Dillon LP, Hemmingway IH, Gearing AJH. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine-activated cultured endothelial cells. Biochem Biophys Res Commun 1992; 187: 548-89.
26. Barker JNWN, Mitra RS, Griffiths CEM et al. Keratinocytes as initiators of inflammation. Lancet 1991; 337: 211-14.
27. Kats AM, Rosenthal D, Sauder DN. Cell adhesion molecules. Structure, function and implication in a variety of cutaneous and other pathologic conditions. Int J Dermatol 1991; 30: 153-60.
28. Kageshita T, Yoshii A, Kimura et al. Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res 1993; 53: 4927-32.
29. Carmona C, Pineyro I, Martinez M, Macedo NA. Soluble E-selectin levels in psoriatic patients treated with cyclosporin. Eur J Dermatol 1996; 6: 297-9.
30. Kowalzick L, Bildau H, Neuber K. et al. Elevated serum-soluble ELAM-1 levels in patients with severe plaque-type psoriasis. Arch Dermatol Res 1994; 286: 414-6.
31. Wintroub BU, Mihm MC, Goetzl EJ et al. Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. N Engl J Med 1978; 8: 417-21.
32. Chorzelski TP, Jablonska S, Beutner EH. Bullous pemphigoid: relationship of immunopathology to clinical findings. In: Immunopathology of the Skin (Beutner EH, Chorzelski TP, Vijay K, eds), 3rd edn. New York: John Wiley. 1987; 337.
33. Kransy SA, Beutner EH, Chorzelski TP. Specificity and sensitivity of indirect and direct immunofluorescent findings in the diagnosis of pemphigus. In: Immunopathology of the Skin (Beutner EH, Chorzelski TP, Vijay K, eds), 3rd edn. New York: John Wiley. 1987; 207.